| GPRO 1.23 40.38% | PCG 14.06 5.95% | LIDR 1.47 27.83% | NVDA 217.44 -1.51% | HKPD 0.1815 -45.54% | TSLL 9.33 -6.42% | NVD 4.05 3.05% | RITR 0.0882 -4.13% | NIO 4.055 -4.14% | FLYE 2.2 61.76% | INTC 88.97 -0.60% | ONDS 7.04 -8.05% | NU 14.46 -0.62% | BITO 10.38 -2.35% | RZLV 2.39 -17.30% | PATH 18.14 -2.84% | SOXL 105.91 -6.10% | AAL 12.95 -3.57% | NOK 9.93 -2.07% | TQQQ 69.15 -3.85% | SPCX 142.23 -1.02% | AAPL 325.13 2.61% | IBIT 43.76 -2.04% | F 13.83 -0.79% | HYG 79.1 -0.89% | SQQQ 39.97 3.79% | PLUG 2.09 -3.24% | SOXS 52.22 6.53% | BIAF 6.59 44.52% | SGOV 100.41 -0.28% | BTG 5.2 -5.11% | CDE 20.2 -2.79% | QID 14.59 2.53% | SOFI 17.05 -4.64% | PFE 28.55 0.32% | SPY 761.78 -0.69% | BMNR 23.37 -7.70% | GRAB 3.46 -2.26% | AIM 0.236 4.42% | RIG 5.92 1.89% | TSLA 356.09 -3.22% | FRVO 19.75 28.41% | LQD 105.22 -0.93% | QQQ 707.64 -1.27% | SSM 4.755 77.43% | IREN 36.82 -0.79% | ETHA 18.23 -2.62% | XLE 64.77 1.27% | T 26.015 0.48% | EWZ 36.57 1.50%

HealthEquity (NASDAQ: HQY) Exceeds Q1 Expectations with Strong Earnings and Revenue Growth

HealthEquity (NASDAQ: HQY) is a company that manages Health Savings Accounts (HSAs) and other consumer-directed benefits for individuals. It acts as both a custodian and administrator, helping people save for healthcare expenses. The company recently announced its financial results for the first quarter ending April 30, 2026, showing performance that exceeded market expectations.

The company reported an earnings per share (EPS) of $1.24. This figure is higher than the Zacks Consensus Estimate of $1.11 per share. It also marks a notable increase from the $0.97 per share that HealthEquity reported in the same quarter of the previous year, showing growth in its profitability per share.

HealthEquity also announced revenue of $354.64 million, which is slightly above the consensus estimate of $352.02 million. This represents a 7% increase in revenue from the year-ago period. This top-line growth contributed to a significant 29% rise in net income, which reached $69.40 million for the quarter.

Supporting this growth, the company's total Health Savings Account (HSA) assets grew by 19% to reach $37.10 billion. To return value to investors, HealthEquity repurchased $123.00 million of its stock. It also announced it is increasing its repurchase program by an additional $1.00 billion, as highlighted by GlobeNewswire.

From a valuation standpoint, HealthEquity has a Price-to-Earnings (P/E) ratio of 33.12. This metric shows what investors are willing to pay for each dollar of company earnings. The company's financial stability appears strong, with a very low Debt-to-Equity ratio of 0.02, indicating it relies minimally on debt for financing.

Published on: May 28, 2026